Michael J. Nelms, PA-C

Michael Nelms practices at Southern California Dermatology in San Clemente, California.

Michael Nelms' NPI, 1235113580, was assigned on November 30, 2005. Michael Nelms holds California license PA14379.

Michael Nelms' primary practice is Southern California Dermatology, at 1300 Avenida Vista Hermosa, San Clemente, CA 92673 in Orange County. The practice phone is (949) 644-0101.

Michael Nelms' primary practice is Southern California Dermatology in San Clemente, California. The medical group on file is West Dermatology. Dmand AI also links Michael Nelms to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Michael Nelms practices. Vendor and product names are available with a free account.

Physician assistant is Michael Nelms' primary specialty in the NPI Registry, under taxonomy code 363A00000X. Michael Nelms is board certified in certified physician assistant by the National Commission on Certification of Physician Assistants (NCCPA). Michael Nelms is licensed in California.

Dmand AI lists acute skin infection, benign or precancerous skin growths, bursitis, cold sores or genital herpes, contact dermatitis, corns and calluses, itchy rashes and minor head injury among the conditions Michael Nelms treats.

CMS data shows 12,237 Medicare services from Michael Nelms across 18 procedure codes in 2024, for 436 Medicare patients. Medicare paid $215,911 for them. Every service was in an office.

CMS counts 436 Medicare patients who saw Michael Nelms in 2024. The largest group is 65 to 74, with 244 patients. 75% of them have high cholesterol, and 61% have high blood pressure. 4% are also on Medicaid. Their average risk score is 0.84, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Michael Nelms' median patient age at 56, with 44% women.

In 2024, Michael Nelms wrote 411 Medicare Part D claims for 186 patients. 95% of them were for generic drugs. CMS names the drug for 341 of them, across 12 drugs with 11 or more claims each, at $8,074 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Michael Nelms for performance year 2024, reported as part of a group. Michael Nelms accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 139 general payments to Michael Nelms from 21 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $551.